Literature DB >> 33642265

Is Elective Neurosurgery Justified During COVID-19 Pandemic?

Arivazhagan Arimappamagan1, George Vilanilam2, Paritosh Pandey3.   

Abstract

BACKGROUND: As the world faces a new viral pandemic, which has spread very rapidly, initial response from most countries was to suspend nonemergent health services so that available resources can be diverted to handle the large numbers of patients with COVID-19 infection. Many societies issued guidelines to suspend or postpone nonemergent surgeries.
METHODS: We reviewed the emerging evidence regarding the impact of COVID-19 infection in neurosurgery and the postponement of elective surgeries. RESULTS AND OBSERVATIONS: COVID-19 infection poses serious threat in hospitals in the form of cross-infection, hospital staff falling sick, with potential risk to overwhelm or paralyze the healthcare. In addition, we have come to realize the significant perioperative morbidity and mortality secondary to active COVID-19 infection. All these strongly favor suspension of elective neurosurgical services. However, these have to be weighed against the fallout due to prolonged postponement of neurosurgical treatment for conditions, which can progress and cause neurological deterioration.
CONCLUSION: This article discusses the contemporary published literature regarding the perioperative risk of COVID-19 infection, impact of postponed surgeries, challenges, risk assessment and guidelines for elective neurosurgery at this point of time.

Entities:  

Keywords:  COVID-19; Cancellation; elective neurosurgery; guidelines; perioperative risk

Mesh:

Year:  2021        PMID: 33642265     DOI: 10.4103/0028-3886.310113

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  5 in total

Review 1.  Immuno-Thrombotic Complications of COVID-19: Implications for Timing of Surgery and Anticoagulation.

Authors:  Connor M Bunch; Ernest E Moore; Hunter B Moore; Matthew D Neal; Anthony V Thomas; Nuha Zackariya; Jonathan Zhao; Sufyan Zackariya; Toby J Brenner; Margaret Berquist; Hallie Buckner; Grant Wiarda; Daniel Fulkerson; Wei Huff; Hau C Kwaan; Genevieve Lankowicz; Gert J Laubscher; Petrus J Lourens; Etheresia Pretorius; Maritha J Kotze; Muhammad S Moolla; Sithembiso Sithole; Tongai G Maponga; Douglas B Kell; Mark D Fox; Laura Gillespie; Rashid Z Khan; Christiaan N Mamczak; Robert March; Rachel Macias; Brian S Bull; Mark M Walsh
Journal:  Front Surg       Date:  2022-05-04

Review 2.  Management of neurosurgical patients during coronavirus disease 2019 pandemics: The Ljubljana, Slovenia experience.

Authors:  Tomaz Velnar; Roman Bosnjak
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

3.  COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting.

Authors:  Jen-Yu Hsu; Po-Yu Liu; Chien-Hao Tseng; Chia-Wei Liu; Wan-Ting Yang; Wei-Hsuan Huang; Shu-Yuan Li; Ya-Chun Liao; Ming-Ju Wu
Journal:  J Multidiscip Healthc       Date:  2021-10-27

Review 4.  How has the COVID-19 pandemic impacted clinical care and research in Neuro-Oncology?

Authors:  Angus Airth; James R Whittle; James Dimou
Journal:  J Clin Neurosci       Date:  2022-09-08       Impact factor: 2.116

5.  Analysis of neurosurgical cases before and during the COVID-19 pandemic from a tertiary care centre in India.

Authors:  Ravi Sharma; Kanwaljeet Garg; Varidh Katiyar; Intekhab Alam; Vivek Tandon; Amol Raheja; Shashwat Mishra; Pavana V; Ashish Suri; P Sarat Chandra; Shashank S Kale
Journal:  World Neurosurg       Date:  2021-06-12       Impact factor: 2.104

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.